Immune Related Adverse Events of Checkpoint Inhibitors
ACR on Air
00:00
Understanding Immune-Related Adverse Events in Cancer Therapy
Exploring the development of immune-related adverse events in cancer therapy, focusing on the impact of immune checkpoint inhibitors like Ipilimumab and PD-1 inhibitors. Discussing the collaboration between rheumatology and oncology in recognizing and managing these adverse events, highlighting the importance of early detection and differentiated diagnosis for inflammatory arthritis in patients undergoing immunotherapy.
Transcript
Play full episode
